Come up with a name for your new list and we'll add to it:
RetroSense Therapeutics raised a round of funding on July 20, 2011. Investors include
Michigan Pre-Seed Capital Fund.
RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (…